Dr. Timothy Michael Zagar, MD

Dr. Zagar practices at Glens Falls Hospital in Glens Falls, New York, part of Albany Med Health System.

Dr. Zagar's NPI, 1972703288, was assigned on July 24, 2007. Dr. Zagar graduated from Icahn School of Medicine at Mount Sinai in 2006. Dr. Zagar holds North Carolina license 149275.

Dr. Zagar's primary practice is Glens Falls Hospital, at 100 Park Street, Glens Falls, NY 12801 in Warren County. The practice phone is (518) 926-1000.

Dr. Zagar's primary practice is Glens Falls Hospital in Glens Falls, New York, part of Albany Med Health System. Dr. Zagar is also affiliated with UNC Hospitals. The medical group on file is Northeastern Radiation Oncology. Dmand AI also links Dr. Zagar to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zagar practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Zagar's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Zagar is licensed in North Carolina.

CMS data shows 2,570 Medicare services from Dr. Zagar across 19 procedure codes in 2024, for 197 Medicare patients. Medicare paid $170,726 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Dr. Zagar in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have cancer, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zagar's median patient age at 71, with 39% women.

In 2024, Dr. Zagar wrote 385 Medicare Part D claims for 128 patients. 89% of them were for generic drugs. CMS names the drug for 278 of them, across 7 drugs with 11 or more claims each, at $52,801 in total drug cost. In 2023, CMS named 180 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Zagar for performance year 2024, reported individually. Dr. Zagar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Zagar from 8 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 74% of the total. Accuray Incorporated paid the most, $2,235. It also lists 2 research payments totaling $1,473 in 2016.

Dr. Zagar graduated from Icahn School of Medicine at Mount Sinai in 2006.